These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29120662)

  • 1. Comparison of MRI visualization between linearly placed iron-containing and non-iron-containing fiducial markers for prostate radiotherapy.
    Tanaka O; Komeda H; Tamaki M; Seike K; Fujimoto S; Yama E; Hirose S; Matsuo M
    Br J Radiol; 2018 Feb; 91(1082):20170612. PubMed ID: 29120662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visibility of an iron-containing fiducial marker in magnetic resonance imaging for high-precision external beam prostate radiotherapy.
    Tanaka O; Komeda H; Hirose S; Taniguchi T; Ono K; Matsuo M
    Asia Pac J Clin Oncol; 2018 Oct; 14(5):e405-e411. PubMed ID: 29193796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fiducial marker for prostate radiotherapy: comparison of 0.35- and 0.5-mm-diameter computed tomography and magnetic resonance images.
    Tanaka O; Komeda H; Iida T; Tamaki M; Seike K; Kato D; Hirose S; Kawaguchi D; Yokoyama T
    Radiol Med; 2017 Mar; 122(3):204-207. PubMed ID: 27981486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fiducial markers visibility and artefacts in prostate cancer radiotherapy multi-modality imaging.
    Osman SOS; Russell E; King RB; Crowther K; Jain S; McGrath C; Hounsell AR; Prise KM; McGarry CK
    Radiat Oncol; 2019 Dec; 14(1):237. PubMed ID: 31878967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of fiducial marker visibility for MRI-only prostate radiotherapy simulation.
    Singhrao K; Ruan D; Fu J; Gao Y; Chee G; Yang Y; King C; Hu P; Kishan AU; Lewis JH
    Phys Med Biol; 2020 Feb; 65(3):035015. PubMed ID: 31881546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a novel liquid fiducial marker for multimodal image guidance in stereotactic body radiotherapy of prostate cancer.
    De Roover R; Crijns W; Poels K; Peeters R; Draulans C; Haustermans K; Depuydt T
    Med Phys; 2018 May; 45(5):2205-2217. PubMed ID: 29537613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visibility and artifacts of gold fiducial markers used for image guided radiation therapy of pancreatic cancer on MRI.
    Gurney-Champion OJ; Lens E; van der Horst A; Houweling AC; Klaassen R; van Hooft JE; Stoker J; van Tienhoven G; Nederveen AJ; Bel A
    Med Phys; 2015 May; 42(5):2638-47. PubMed ID: 25979055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving fiducial and prostate capsule visualization for radiotherapy planning using MRI.
    Pathmanathan AU; Schmidt MA; Brand DH; Kousi E; van As NJ; Tree AC
    J Appl Clin Med Phys; 2019 Mar; 20(3):27-36. PubMed ID: 30756456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using C-Arm X-ray images from marker insertion to confirm the gold fiducial marker identification in an MRI-only prostate radiotherapy workflow.
    Gustafsson C; Persson E; Gunnlaugsson A; Olsson LE
    J Appl Clin Med Phys; 2018 Nov; 19(6):185-192. PubMed ID: 30354010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Registration free automatic identification of gold fiducial markers in MRI target delineation images for prostate radiotherapy.
    Gustafsson C; Korhonen J; Persson E; Gunnlaugsson A; Nyholm T; Olsson LE
    Med Phys; 2017 Nov; 44(11):5563-5574. PubMed ID: 28803447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automatic Substitute Computed Tomography Generation and Contouring for Magnetic Resonance Imaging (MRI)-Alone External Beam Radiation Therapy From Standard MRI Sequences.
    Dowling JA; Sun J; Pichler P; Rivest-Hénault D; Ghose S; Richardson H; Wratten C; Martin J; Arm J; Best L; Chandra SS; Fripp J; Menk FW; Greer PB
    Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1144-53. PubMed ID: 26581150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Precision of T2 TSE MRI-CT-image fusions based on gold fiducials and repetitive T2 TSE MRI-MRI-fusions for adaptive IGRT of prostate cancer by using phantom and patient data.
    Wegener D; Zips D; Thorwarth D; Weiß J; Othman AE; Grosse U; Notohamiprodjo M; Nikolaou K; Müller AC
    Acta Oncol; 2019 Jan; 58(1):88-94. PubMed ID: 30264629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI-alone radiation therapy planning for prostate cancer: Automatic fiducial marker detection.
    Ghose S; Mitra J; Rivest-Hénault D; Fazlollahi A; Stanwell P; Pichler P; Sun J; Fripp J; Greer PB; Dowling JA
    Med Phys; 2016 May; 43(5):2218. PubMed ID: 27147334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The advantage of iron-containing fiducial markers placed with a thin needle for radiotherapy of liver cancer in terms of visualization on MRI: an initial experience of Gold Anchor.
    Tanaka O; Nishigaki Y; Hayashi H; Iida T; Yokoyama T; Takenaka E; Yama E; Tomita E
    Radiol Case Rep; 2017 Jun; 12(2):416-421. PubMed ID: 28491201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of gold fiducial marker manual localisation for magnetic resonance-only prostate radiotherapy.
    Maspero M; Seevinck PR; Willems NJW; Sikkes GG; de Kogel GJ; de Boer HCJ; van der Voort van Zyp JRN; van den Berg CAT
    Radiat Oncol; 2018 Jun; 13(1):105. PubMed ID: 29871656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Internal fiducial markers and susceptibility effects in MRI-simulation and measurement of spatial accuracy.
    Jonsson JH; Garpebring A; Karlsson MG; Nyholm T
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1612-8. PubMed ID: 21477942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiotherapy for prostate cancer: Effect of gold fiducial markers on diffusion-weighted magnetic resonance imaging.
    Tanaka O; Maejima R; Yama E; Taniguchi T; Ono K; Makita C; Matsuo M
    Asia Pac J Clin Oncol; 2021 Feb; 17(1):79-83. PubMed ID: 32969171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A generative adversarial network-based (GAN-based) architecture for automatic fiducial marker detection in prostate MRI-only radiotherapy simulation images.
    Singhrao K; Fu J; Parikh NR; Mikaeilian AG; Ruan D; Kishan AU; Lewis JH
    Med Phys; 2020 Dec; 47(12):6405-6413. PubMed ID: 32989773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-center experience in prostate fiducial marker placement: technique and midterm follow-up.
    Kably I; Bordegaray M; Shah K; Salsamendi J; Narayanan G
    J Vasc Interv Radiol; 2014 Jul; 25(7):1125-1132.e1. PubMed ID: 24788207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrogel Spacer Prospective Multicenter Randomized Controlled Pivotal Trial: Dosimetric and Clinical Effects of Perirectal Spacer Application in Men Undergoing Prostate Image Guided Intensity Modulated Radiation Therapy.
    Mariados N; Sylvester J; Shah D; Karsh L; Hudes R; Beyer D; Kurtzman S; Bogart J; Hsi RA; Kos M; Ellis R; Logsdon M; Zimberg S; Forsythe K; Zhang H; Soffen E; Francke P; Mantz C; Rossi P; DeWeese T; Hamstra DA; Bosch W; Gay H; Michalski J
    Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):971-977. PubMed ID: 26054865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.